Probiotic Bacterial Molecule-Based Solutions for Diverse Industries

Publication ID: 24-11857581_0007_PTD
Published: October 28, 2025
Category:New Applications & Use Cases

Legal Citation

pr1or.art Inc., “Probiotic Bacterial Molecule-Based Solutions for Diverse Industries,” Published Technical Disclosure No. 24-11857581_0007_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857581_0007_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,581.

Summary of the Inventive Concept

This inventive concept leverages the antiviral properties of probiotic bacterial molecules to develop novel solutions for reducing viral contamination and transmission in various industries, including wastewater treatment, agriculture, food processing, animal husbandry, and recreational water sources.

Background and Problem Solved

The original patent disclosed the use of probiotic bacterial molecules for controlling pathogenic viruses in mammals. However, the patent's scope was limited to medical applications. The present inventive concept addresses the need for innovative solutions to tackle viral contamination in diverse industries, where existing methods are often ineffective or inadequate.

Detailed Description of the Inventive Concept

The new inventive concept involves the application of probiotic bacterial molecule-based treatments to various industries, including: 1) industrial wastewater treatment to minimize viral contamination; 2) agricultural soil to reduce viral infections in plants and improve crop yields; 3) food processing facilities to reduce viral contamination on surfaces and equipment; 4) animal husbandry to reduce viral transmission through animal feed and water; and 5) recreational water sources to minimize viral contamination. These treatments utilize the antiviral properties of probiotic bacterial molecules, which have been shown to be effective against various viruses.

Novelty and Inventive Step

The new inventive concept introduces a paradigm shift by applying the core technology of the original patent to entirely new industries and use cases, thereby providing a novel and non-obvious solution to the problem of viral contamination. The inventive step lies in the recognition of the potential of probiotic bacterial molecules to address viral contamination in diverse industries, and the development of tailored solutions for each industry.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept may include the use of different probiotic bacterial strains, varying concentrations of probiotic bacterial molecules, or combination therapies with other antiviral agents. Variations of the inventive concept may also involve the development of probiotic bacterial molecule-based treatments for other industries, such as textiles or cosmetics.

Potential Commercial Applications and Market

The inventive concept has significant commercial potential, as it addresses a pressing need for effective solutions to viral contamination in various industries. The target markets include wastewater treatment facilities, agricultural companies, food processing industries, animal husbandry businesses, and recreational water source management companies. The potential market size is substantial, with opportunities for licensing, partnerships, and product sales.

Field of Art

Microbiology, virology, and probiotic applications with a focus on antiviral treatments and bacterial molecular interactions

Person of Ordinary Skill (PHOSITA) Profile

A researcher or scientist with advanced degrees in microbiology, biotechnology, or related fields, possessing expertise in probiotic bacterial strains, their molecular mechanisms, and applications in viral infection prevention

Obviousness Rationale

A PHOSITA would recognize the inherent versatility of probiotic bacterial molecules in combating viral infections, understanding that the core antiviral mechanism disclosed in the source patent could be readily extended to diverse industrial applications. The systematic approach of applying known antiviral probiotic technologies to different contamination scenarios represents a logical and predictable extension of the original invention. The technical principles underlying viral reduction through probiotic bacterial molecules are fundamentally consistent across various environmental and industrial contexts.

Obvious Combinations & Variations

Source Patent Element
Antiviral method using probiotic bacterial molecules targeting Rotavirus
PTD Variation
Applying probiotic bacterial molecules to industrial wastewater treatment for viral contamination reduction
Obviousness Reasoning
Known technique of using probiotic molecules to inhibit viral transmission, with predictable results when applied to alternative contamination environments
Source Patent Element
Specific Lactobacillus and Bifidobacterium strains with antiviral properties
PTD Variation
Utilizing probiotic bacterial molecules in agricultural soil to reduce plant viral infections
Obviousness Reasoning
Predictable extension of known antiviral mechanisms to plant protection, representing a finite and obvious solution to viral contamination challenges
Source Patent Element
Peptide-based molecules secreted by probiotic bacteria
PTD Variation
Developing probiotic bacterial molecule treatments for food processing facility surface decontamination
Obviousness Reasoning
Obvious application of known antiviral molecular mechanisms to surface contamination prevention, using standard design choices in biotechnology
Source Patent Element
Method of administering probiotic bacterial molecules to mammals
PTD Variation
Implementing probiotic treatments in animal husbandry to reduce viral transmission through feed and water
Obviousness Reasoning
Logical and predictable adaptation of existing antiviral treatment methodology to alternative biological systems
35 U.S.C. § 103 Summary: Based on the teachings of US Patent 11857581 and the disclosed variations, a person of ordinary skill in the art would find the proposed industrial applications of probiotic bacterial molecules for viral contamination reduction to be obvious and lacking inventive step. The systematic extension of known antiviral probiotic technologies to diverse contamination scenarios represents a predictable variation within the ordinary capabilities of skilled practitioners in the field of microbial antiviral treatments.

Original Patent Information

Patent NumberUS 11,857,581
TitleAntiviral methods and compositions comprising probiotic bacterial molecules
Assignee(s)MICROSINTESIS INC.